Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Merck Serono headquarters

Merck Serono halts Movectro European licence application

February 18, 2011 Medical Communications, Sales and Marketing Cladribine, MS, Merck KGaA, Merck Serono, Movectro, fingolimod, gilenya, multiple sclerosis

Merck Serono has withdrawn its European licence application for multiple sclerosis drug Movectro. Movectro (cladribine) is a new oral treatment …
News

Value-based pricing will not harm industry, says NICE chief

February 18, 2011 Sales and Marketing Health Select Committee, Health and Social Care Bill, NHS reform, NICE, Sir Andrew Dillon, value-based pricing

NICE’s chief executive Sir Andrew Dillon says he believes plans to introduce value-based pricing of medicines will not have a …
News

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011 Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …
News

Bennett appointed chairman of Monitor

February 18, 2011 Sales and Marketing Monitor, NHS

Monitor, the body which will take on a powerful new role in regulating competition in the NHS, has a new …
News

Vidaza patient access scheme sways NICE

February 17, 2011 Sales and Marketing Celgene, NICE, Vidaza

Celgene’s Vidaza has been recommended by NICE in final draft guidance issued today. Vidaza (azacitidine) is recommended as a treatment …
News

e-Therapeutics success in £17 million financing

February 17, 2011 Research and Development, Sales and Marketing ETS2101, Invesco, e-Therapeutics

UK drug discovery and development company e-Therapeutics has successfully raised £17.6 million through a new share issue. The deal attracted …
News
Lilly HQ

Lilly hails progress of new R&D approaches

February 16, 2011 Research and Development, Sales and Marketing Chorus, Mirror Portfolio, R&D, lilly

Lilly says two of its experimental approaches to re-designing R&D are beginning to pay off.Like all of its peers, the …
Feature

Companies join forces to promote AF awareness

February 16, 2011 Medical Communications, Sales and Marketing AF, Multaq, Pradaxa, apixaban, atrial fibrillation

Boehringer Ingelheim and Sanofi-Aventis are to co-sponsor the World Heart Federation’s global atrial fibrillation (AF) education campaign. AF AWARE was …
News

Sanofi seals Genzyme deal for $20 billion

February 16, 2011 Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi-Aventis has finally agreed a deal to buy Genzyme for $20.1 billion after eight months of wrangling with the US …
News
Obama

Obama’s generics plan criticised

February 15, 2011 Sales and Marketing FDA, Obama, PhRMA, generics, reform

US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …
News

Merck repels jaw injury claim

February 15, 2011 Sales and Marketing Fosamax, Merck, US, lawsuit

A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …
News

R&D productivity worse than previously reported

February 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing BIO, BMT, FDA, R&D

A new analysis of pharma’s R&D pipelines suggests the overall success rate for drugs moving from clinical trials to FDA …
News

Germany’s Merck pledges emphasis on women executives

February 14, 2011 Sales and Marketing Merck KGaA, Women in pharma, equality

Merck KGaA has set itself the goal of increasing its proportion of women managers over the next five years. The …
News

7 Wins for Pulsar!

February 11, 2011 Medical Communications, Sales and Marketing

Pulsar have done very well of late and managed to bag 1 silver Rx award and  6  New York Rx …
Feature
Thought Leadership

Shire thrives on specialist portfolio

February 11, 2011 Sales and Marketing 2010 pharma results, ADHD, Shire, Vyvanse

Speciality pharma company Shire has posted sales growth of 16%, led by its ADHD treatment Vyvanse. Sales of Vyvanse rose …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026